HIGHLAND CAPITAL MANAGEMENT LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2019$921,000
-0.5%
17,5000.0%0.05%
-6.9%
Q1 2019$926,000
+0.2%
17,500
-22.2%
0.06%
-18.3%
Q4 2018$924,000
+62.1%
22,500
+50.0%
0.07%
+129.0%
Q3 2018$570,000
-15.9%
15,0000.0%0.03%
-18.4%
Q2 2018$678,000
-12.3%
15,000
-6.2%
0.04%
-5.0%
Q1 2018$773,000
+44.5%
16,000
+17.6%
0.04%
+60.0%
Q4 2017$535,000
-60.7%
13,600
-83.5%
0.02%
-55.4%
Q2 2016$1,363,00082,2000.06%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders